From April 1, 2024 to May 23, 2024, the company has repurchased 181,433 shares, representing 0.04% for CNY 2.44 million. With this, the company has completed the repurchase of 2,139,878 shares, representing 0.51% for CNY 30.01 million under the buyback announced on February 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.93 CNY | -0.17% | +2.32% | -21.15% |
06-28 | Huiyu Pharmaceutical Unit Gets Nod to Market Three Cancer Drugs in Uzbekistan | MT |
06-20 | France Grants Marketing Approval for Huiyu Pharma's Osteoporosis Injection | MT |
1st Jan change | Capi. | |
---|---|---|
-21.15% | 698M | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- 688553 Stock
- News Sichuan Huiyu Pharmaceutical Co., Ltd.
- Tranche Update on Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.